Syra Health Corp.

What they do

Syra Health provides prevention-focused healthcare services and products across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. Its customers are primarily government and commercial healthcare organizations. The company is headquartered in Carmel, Indiana. Its workforce offerings operate in the employment-services space, including contracts with public health agencies and state facilities.

Revenue drivers

• Healthcare workforce and staffing contracts — Contract work for public-sector customers such as a one-year extension with the Indiana Veterans' Home and county public health agencies; the company describes continued demand for healthcare workforce solutions as a stated growth driver.
• Population health solutions — Analytics as a service, epidemiology, and health equity analytics delivered by health economists, data scientists and biostatisticians; management cited growth in population health solutions in Q2 2026 commentary.
• Health education and learning platforms — Training and education services, including an Indiana FSSA/DDRS contract amendment extending a learning management platform to the state's Bureau of Disability Services through October 2028.
• Behavioral/mental health and digital health products — Syrenity, a mental health app launched in Q4 2024, plus digital health offerings such as SyraBot, CarePlus and patient engagement services; these are described as being developed or launched rather than established revenue lines.

Recent performance

Q2 2026 revenue was $2.4 million, up 23% from $1.9 million in the prior-year period, and net income was $250,242 versus a net loss of $(63,596) a year earlier. Gross margin rose to 44.5% from 38.7%, which the company called its highest quarterly gross margin. EPS improved to $0.02 from $(0.01), and EBITDA went from $(53,760) to positive $253,200. For the six months ended June 30, 2026, net income was $491,221 versus a $(535,861) loss, and operating cash flow was $643,183 versus $85,754. Full-year 2025 revenue was $7.2 million with a net loss of $896,333.

Strategy

Management is focused on sustaining full-year profitability in 2026 after two consecutive profitable quarters, while growing revenue and expanding gross margin through higher-value solutions. The company is pursuing contract extensions with existing public-sector customers and an amendment extending its Indiana learning management platform through October 2028. It formed a Business Advisory Council to support market expansion and expects near-term approval of the CMS ACCESS Model in partnership with HealthSync, which it describes as a potential durable revenue source over the next 10 years. It continues to invest in technology-enabled products including Syrenity, SyraBot and CarePlus.

Risks

• Customer concentration in government contracts — Revenue depends on public health and state agency contracts that must be renewed or extended, as shown by the company's reliance on renewals such as Wake County Public Health and the Indiana Veterans' Home.
• History of losses and thin profitability — The company reported net losses in each year from 2022 through 2025, including a $3.8 million loss in 2024, before turning profitable only in the first half of 2026.
• Quarterly revenue variability — Management states that revenue recognition, timing, and contract milestones are expected to continue to cause quarterly variability.
• Dependence on unapproved or early-stage products — Anticipated CMS ACCESS Model approval and newer products such as Syrenity and SyraBot are not yet proven revenue sources and may not materialize as expected.

Outlook

Management targets full-year profitability for 2026 following two consecutive profitable quarters, while noting expected quarterly variability from revenue recognition and contract timing. The company anticipates near-term CMS ACCESS Model approval with HealthSync, which it expects to be a durable revenue source over the next 10 years. It also points to recent contract extensions and population health growth as momentum for the remainder of the year.